Genome-wide association study (GWAS)............97–106,
394, 395, 397–399, 405
Gini correlation coefficient (GCC)....................... 11, 139
Glioblastoma (GBM)...........................................192, 356
H
Hidden Markov model (HMM) ........................196, 236,
243, 360, 401
High-throughput sequencing (HTS).........................2–4,
15, 30–42, 194, 404
Human Metabolites Database (HMDB)....................112,
113, 266, 279, 284
I
Ictidomys tridecemlineatus.............................................. 31
Integrated Clustering of Multidimensional
biomedical data (ICM)............................124, 125
Integrative analysis..............................................109–117,
119–127
K
K-nearest neighbor (kNN).................................249, 250,
252, 255, 258
Kyoto Encyclopedia of Genes and Genomes
(KEGG)...................................................9, 17, 24,
112, 113, 120, 150, 158, 177, 283, 284
L
Leave-one-out cross-validation (LOOCV).................215,
229, 230
Linear discriminant analysis (LDA).............................122,
123, 321, 346
Local lazy learning (LLL).............................................251
Local lazy regression (LLR).........................................251
Local tangent space alignment (LTSA) ..............122, 123
Long noncoding RNAs (lncRNAs)............................113,
206, 209–211, 213–215, 217, 218, 313
Long-range library capture hybridization
(LR-LCH) .................................32, 34, 38, 40, 42
Long-range polymerase chain reaction
(LR-PCR)..................................32, 33, 35, 36, 38
M
Machine learning.......................................... 86,111, 122,
183–194, 196–198, 211, 215, 224–228, 230,
231, 243, 247–259
Magnetic resonance (NMR)........................................197,
266, 272, 274, 275, 277–279, 281, 284
Matthew’s correlation coefficient (MCC)..................230,
242, 244
Messenger RNA (mRNA) .......................................15–17,
26, 45, 48, 109, 116–120, 123, 156, 172, 189,
191, 193, 210, 217, 312, 334, 353, 354, 402
MicroRNA (miRNA)......................................15, 45,113,
117–120, 123, 191, 205, 210, 213
Microscopic observation drug susceptibility
(MODS).............................................................377
Minimal residual disease (MRD)............................ 47, 68,
390, 398
Mitochondrial DNA (mtDNA).............................. 32, 33,
38, 313
Mitochondrial genome (mitogenome).........................32,
33, 35, 38–40, 314, 317, 319
Modified multiple annealing and looping-based
amplification cycles (MALBAC).......................334
Molecular Evolutionary Genetics Analysis
(MEGA)............................................................... 11
Mutated allele frequency (MAF)...................................72,
81, 91, 92, 102
Mutual information (MI)....................................139, 148
Mycobacterium tuberculosis(MTB).............................375,
377, 379, 380
N
Naive Bayes (NB)................................................185, 187,
191, 211, 252, 255, 258
Non-coding RNA (ncRNA)..........................................15,
205–211, 213–215, 217, 218, 313, 315
O
O-linkedN-acetylglucosamine
(O-GlcNAc)..............................................235–244
Online Mendelian Inheritance in Man
(OMIM)....................................................207, 208
Operational taxonomy units (OTUs)..........................194
P
Partial order optimum likelihood (POOL).................190
Phage lambda............................................................31, 42
Piwi-interacting RNA (piRNA)...........................205, 210
Post-bisulfite adaptor tagging (PBAT)........................333
Precision (PR).....................................................111, 125,
190, 196, 230, 231, 252, 312, 404
Precision-recall (PR).....................................................231
Principal component analysis (PCA)...........................116,
169, 171, 176, 178, 258, 282, 316, 320, 321,
324, 349, 352, 356
Protein-protein interactions (PPIs).............................113,
119, 155, 191
Pseudomonas fluorescens................................................... 30
Q
Quality control (QC)....................................................... 6,
15–17, 19, 70, 72, 73, 76, 77, 86, 87, 99, 102,
103, 107, 121, 277, 280, 282, 312, 314, 324,
335, 336, 339, 352, 359, 395
Quantitative PCR (qPCR)...................................333, 398
416
COMPUTATIONALSYSTEMSBIOLOGY:METHODS ANDPROTOCOLS
Index